These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 38051425)
1. A global systematic evidence review with meta-analysis of the epidemiological characteristics of the 2022 Mpox outbreaks. Okoli GN; Van Caeseele P; Askin N; Abou-Setta AM Infection; 2024 Jun; 52(3):901-921. PubMed ID: 38051425 [TBL] [Abstract][Full Text] [Related]
2. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences. Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159 [TBL] [Abstract][Full Text] [Related]
3. Willingness to receive mpox vaccine among men who have sex with men: a systematic review and meta-analysis. Liu J; Liu S; Yu S; Du X; Hao J; Hui R; Buh A; Chen W; Chen J BMC Public Health; 2024 Jul; 24(1):1878. PubMed ID: 39010029 [TBL] [Abstract][Full Text] [Related]
4. A seroprevalence study indicates a high proportion of clinically undiagnosed MPXV infections in men who have sex with men in Berlin, Germany. Marcus U; Michel J; Lunchenkov N; Beslic D; Treindl F; Surtees R; Weber C; Baumgarten A; Nitsche A; Stern D BMC Infect Dis; 2024 Oct; 24(1):1153. PubMed ID: 39396951 [TBL] [Abstract][Full Text] [Related]
5. Scenarios of future mpox outbreaks among men who have sex with men: a modelling study based on cross-sectional seroprevalence data from the Netherlands, 2022. Shamier MC; Zaeck LM; Götz HM; Vieyra B; Verstrepen BE; Wijnans K; Welkers MR; Hoornenborg E; van Cleef BA; van Royen ME; Jonas KJ; Koopmans MP; de Vries RD; van de Vijver DA; GeurtsvanKessel CH Euro Surveill; 2024 Apr; 29(17):. PubMed ID: 38666400 [TBL] [Abstract][Full Text] [Related]
7. Immune responses associated with mpox viral clearance in men with and without HIV in Spain: a multisite, observational, prospective cohort study. Moraes-Cardoso I; Benet S; Carabelli J; Perez-Zsolt D; Mendoza A; Rivero A; Alemany A; Descalzo V; Alarcón-Soto Y; Grifoni A; Sette A; Moltó J; Marc A; Marks M; Mitjà O; Brander C; Paredes R; Izquierdo-Useros N; Carrillo J; Suñer C; Olvera A; Mothe B; Lancet Microbe; 2024 Aug; 5(8):100859. PubMed ID: 38857615 [TBL] [Abstract][Full Text] [Related]
8. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model. Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661 [TBL] [Abstract][Full Text] [Related]
9. Estimating the relative importance of epidemiological and behavioural parameters for epidemic mpox transmission: a modelling study. Chaturvedi M; Rodiah I; Kretzschmar M; Scholz S; Lange B; Karch A; Jaeger VK BMC Med; 2024 Jul; 22(1):297. PubMed ID: 39020322 [TBL] [Abstract][Full Text] [Related]
10. Emergence of mpox in the Eastern Mediterranean Region: Data assessment and implications for a public health response. Hermez J; El Helou R; Sawaya T; Sader G; Jamil MS; Alaama AS; Rizk NA J Infect Public Health; 2024 Nov; 17(11):102565. PubMed ID: 39427467 [TBL] [Abstract][Full Text] [Related]
11. How to recognize and respond to monkeypox 2022 outbreak in non-endemic countries: a narrative review. Qiu ZY; Tao YH; Zheng SL; Sun XD; Chi YH; Sun X; Wang JR Eur Rev Med Pharmacol Sci; 2022 Nov; 26(22):8620-8630. PubMed ID: 36459045 [TBL] [Abstract][Full Text] [Related]
12. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone. Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924 [TBL] [Abstract][Full Text] [Related]
13. Mpox outbreak in Rio de Janeiro, Brazil: A translational approach. Lira GS; Ota VA; Melo MQS; Castiñeiras ACP; Leitão IC; Silva BO; Mariani D; Gonçalves CCA; Ribeiro LJ; Halpern M; Abreu TF; Carneiro FA; Scheid HT; Souza LAV; Rodrigues DGM; Cruz NVG; Cony A; Carvalho S; de Lima LPO; Viala VL; Caldas LA; de Souza W; Higa LM; Voloch CM; Ferreira OC; Damaso CR; Galliez RM; Faffe DS; Tanuri A; Castiñeiras TMPP J Med Virol; 2024 May; 96(5):e29621. PubMed ID: 38654686 [TBL] [Abstract][Full Text] [Related]
15. Comparison of cognitive behaviour therapy versus activity management, both delivered remotely, to treat paediatric chronic fatigue syndrome/myalgic encephalomyelitis: the UK FITNET-NHS RCT. Crawley E; Anderson E; Cochrane M; Shirkey BA; Parslow R; Hollingworth W; Mills N; Gaunt D; Treneman-Evans G; Rai M; Macleod J; Kessler D; Pitts K; Cooper S; Loades M; Annaw A; Stallard P; Knoop H; Van de Putte E; Nijhof S; Bleijenberg G; Metcalfe C Health Technol Assess; 2024 Oct; 28(70):1-134. PubMed ID: 39485730 [TBL] [Abstract][Full Text] [Related]
16. Paediatric, maternal, and congenital mpox: a systematic review and meta-analysis. Sanchez Clemente N; Coles C; Paixao ES; Brickley EB; Whittaker E; Alfven T; Rulisa S; Agudelo Higuita N; Torpiano P; Agravat P; Thorley EV; Drysdale SB; Le Doare K; Muyembe Tamfum JJ Lancet Glob Health; 2024 Apr; 12(4):e572-e588. PubMed ID: 38401556 [TBL] [Abstract][Full Text] [Related]
17. Tamoxifen for adults with hepatocellular carcinoma. Naing C; Ni H; Aung HH Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014869. PubMed ID: 39132750 [TBL] [Abstract][Full Text] [Related]
18. Clinical features and viral load variations of Mpox: a retrospective study in Chongqing, China. Yang S; Xia C; Zhang Y; Shen Y; Xia C; Lu Y; Su S; Deng C; Harypursat V; Wang J; Yuan J; Chen Y BMC Infect Dis; 2024 Jun; 24(1):641. PubMed ID: 38926635 [TBL] [Abstract][Full Text] [Related]
19. Clinical and laboratory predictors of mpox severity and duration: an Italian multicentre cohort study (mpox-Icona). Mazzotta V; Nozza S; Lanini S; Moschese D; Tavelli A; Rossotti R; Fusco FM; Biasioli L; Matusali G; Raccagni AR; Mileto D; Maci C; Lapadula G; Di Biagio A; Pipitò L; Tamburrini E; Monforte AD; Castagna A; Antinori A; EBioMedicine; 2024 Sep; 107():105289. PubMed ID: 39178746 [TBL] [Abstract][Full Text] [Related]
20. Monitoring an Emergent Pathogen at Low Incidence in Wastewater Using qPCR: Mpox in Switzerland. Julian TR; Devaux AJ; Brülisauer L; Conforti S; Rusch JC; Gan C; Bagutti C; Stadler T; Kohn T; Ort C Food Environ Virol; 2024 Sep; 16(3):269-279. PubMed ID: 38780822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]